We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$3.54B
AUM Growth
+$107M
Cap. Flow
+$179M
Cap. Flow %
5.05%
Top 10 Hldgs %
20.31%
Holding
4,474
New
404
Increased
1,575
Reduced
1,479
Closed
707
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
226
Starbucks
SBUX
$123B
$2.49M 0.07%
27,762
+7,820
+39% +$740K
BX icon
227
Blackstone
BX
$107B
$2.48M 0.07%
21,601
+403
+2% +$52.4K
PAYX icon
228
Paychex
PAYX
$45.2B
$2.47M 0.07%
26,867
+22,758
+554% +$2.25M
LRCX icon
229
Lam Research
LRCX
$378B
$2.46M 0.07%
11,515
+5,235
+83% +$1.17M
ROP icon
230
Roper Technologies
ROP
$42.2B
$2.45M 0.07%
6,931
+4,428
+177% +$1.63M
VONG icon
231
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
$2.44M 0.07%
22,277
-135,011
-86% -$15.8M
TLH icon
232
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
$2.43M 0.07%
24,175
-27,720
-53% -$2.83M
FTSM icon
233
First Trust Enhanced Short Maturity ETF
FTSM
$6.53B
$2.42M 0.07%
40,528
-13,045
-24% -$782K
FVD icon
234
First Trust Value Line Dividend Fund
FVD
$8.26B
$2.42M 0.07%
51,351
-1,275
-2% -$61.2K
TLT icon
235
iShares 20+ Year Treasury Bond ETF
TLT
$46.8B
$2.39M 0.07%
27,585
-30,083
-52% -$2.64M
VHT icon
236
Vanguard Health Care ETF
VHT
$19.3B
$2.39M 0.07%
8,776
+2,239
+34% +$640K
TFX icon
237
Teleflex
TFX
$5.92B
$2.37M 0.07%
19,836
-36
-0.2% -$3.97K
SCHW
238
Charles Schwab
SCHW
$191B
$2.32M 0.07%
24,694
-8,558
-26% -$839K
SPYM
239
State Street SPDR Portfolio S&P 500 ETF
SPYM
$171B
$2.31M 0.07%
30,216
+25,471
+537% +$2.04M
LOW icon
240
Lowe's Companies
LOW
$117B
$2.31M 0.07%
9,759
+261
+3% +$68.1K
BALL icon
241
Ball Corp
BALL
$16.9B
$2.29M 0.06%
38,723
+32,138
+488% +$1.95M
PM icon
242
Philip Morris
PM
$299B
$2.28M 0.06%
13,799
-7,729
-36% -$1.34M
SPTS icon
243
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
$2.27M 0.06%
77,637
-5,166
-6% -$151K
ADI icon
244
Analog Devices
ADI
$175B
$2.26M 0.06%
7,052
-1,230
-15% -$391K
ORLY icon
245
O'Reilly Automotive
ORLY
$71.6B
$2.25M 0.06%
24,424
-58,734
-71% -$5.51M
MMM icon
246
3M
MMM
$89.9B
$2.25M 0.06%
15,522
+7,477
+93% +$1.19M
CL icon
247
Colgate-Palmolive
CL
$72.3B
$2.25M 0.06%
26,413
+18,893
+251% +$1.68M
PFE icon
248
Pfizer
PFE
$159B
$2.24M 0.06%
79,856
+5,834
+8% +$155K
SHW icon
249
Sherwin-Williams
SHW
$83.7B
$2.22M 0.06%
6,941
-497
-7% -$171K
ICSH icon
250
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.58B
$2.22M 0.06%
43,950
+3,717
+9% +$188K

Similar funds

Arax Advisory Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arax Advisory Partners held 4,474 positions worth $3.54B, up 3.1% from $3.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners deployed $179M of net new capital in Q1 2026, opening 404 new positions and adding to 1,575 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 68% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $32.9M trimmed.

  • Arax Advisory Partners's largest Q1 2026 buy was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.
  • Arax Advisory Partners added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $59M increase.
  • Arax Advisory Partners's biggest Q1 2026 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $32.9M.
  • Arax Advisory Partners fully exited Willis Towers Watson in Q1 2026, selling an estimated $746K.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.54B portfolio in Q1 2026.
  • Arax Advisory Partners opened 404 new positions and closed 707 in Q1 2026.
  • Arax Advisory Partners's portfolio value rose 3.1% quarter-over-quarter to $3.54B.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.